Go to deals
Industrial Machinery & Components

Doosan Skoda Power has been listed on the Prague Stock Exchange with a US$104 million initial public offering

Doosan Skoda Power and its parent company, Doosan Power Systems, have placed just over US$114 million (€100 million) of the company’s shares, of which US$31.4 million (€27.6 million) supported a 10% capital increase and US$72.4 million (€63.7 million), representing 23% of the pre-transaction share capital, was returned to the selling shareholder. This amount includes US$10.5 million (€9.2 million) in greenshoe shares, equivalent to 10% of the base deal.

Following the IPO, the free float stood at 33%, with no stabilization measures implemented. The proceeds from the capital increase will enhance the company’s overall capabilities and competitiveness through medium-term investments in new machinery, facilities, digitalization and IT.

Headquarted in Pilsen, Czech Republic, Doosan Skoda Power is a leading steam turbine manufacturer. Its immediate parent company is Doosan Power Systems, the selling shareholder and part of Doosan Enerbility, which acquired the company in 2009. Doosan Skoda Power provides products and services to customers across several sectors, including waste-to-energy, utilities, pulp and paper, mining and refining.

Oaklins’ team in the Czech Republic acted as the joint global coordinator on this transaction, which targeted Czech and European institutional investors, Czech family offices and high-net-worth individuals (HNWI). Leading the syndicate, the team secured orders from 44 investors, with over 90% of the demand at the offer price coming from Czech-based investors. This highlights the strong appetite and capacity of local investors to provide substantial demand, even for large transactions on the Prague Stock Exchange. The team also engaged leading Czech brokers as selling agents to tap into the new, non-institutional sector. The books were covered within the price range of US$10-11.8 (CZK220-260) on the fourth day of the bookbuilding period, and throughout the price range on the following day. On the final day of bookbuilding, the syndicate guided investors towards a revised price range of US$10.9-11.8 (CZK240-260). The books closed on 5 February 2025 with a significant oversubscription and a strong investor structure at the deal price of US$10.9 (CZK240). The shares debuted on the Prague Stock Exchange on 6 February, opening at US$11.8 (CZK260), representing an 8.3% increase, and closing the day at US$12.9 (CZK284), a premium of 18.3% over the IPO price.

Talk to the deal team

Miloš Čebík

Director
Prague, Czech Republic
Oaklins WOOD & Co.

Oliver Polyák

Senior Manager
Prague, Czech Republic
Oaklins WOOD & Co.

Samuel Čellár

Associate
Prague, Czech Republic
Oaklins WOOD & Co.

Jan Švejda

Associate
Prague, Czech Republic
Oaklins WOOD & Co.

Related deals

F.EE has been acquired by One Equity Partners
Industrial Machinery & Components

F.EE has been acquired by One Equity Partners

F.EE GmbH, one of Germany’s leading providers of innovative solutions in mechanical engineering, automation hardware, cabinet control, software and robot programming, has been acquired by One Equity Partners. This transaction will strengthen the private equity firm’s operations in the industrial automation space. The sellers have reinvested and will remain involved in the business for the coming years.

Learn more
SRT Marine has completed a placing and subscription
TMT

SRT Marine has completed a placing and subscription

SRT Marine Systems plc has announced an equity raise of at least US$22 million at US$1.10 per share representing a 5.75% discount, through a US$19.4 million accelerated bookbuild placing and a US$2 million subscription by Ocean Infinity, alongside a separate retail offer of up to US$1.3 million.

Learn more
IXICO has completed a fundraising
Healthcare

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Learn more